Investors & mediaCalendar Year-end Report 2018

Year-end Report 2018

Oncopeptides AB will release its Year-end Report on 22 February at 8:00 am CET. 

The company’s CEO Jakob Lindberg will summarize the financial year 2018 and address questions from investors, analysts and media at 14:00 CET, 22 February.

An audiocast to the presentation will be available at:

Time for webcast – 14.00 (CET) on 22 February
 Dial in number from Sweden: +46856642706
Dial in number from UK: +443333009270
Dial in number US: +18335268382

For more information, please contact:

Rein Piir, Head of Investor Relations at Oncopeptides
Cell phone: +46 70 853 72 92

Upcoming events

International Myeloma Workshop (IMW) 2019

In Boston. Oncopeptides to present: Two Poster presentations - Quality of life of treatment for relapsed/refractory multiple myeloma: a systematic review - Aminopeptidase gene expression in myeloma And...
Back to top